Skip to main content
Clinical Trials/CTRI/2024/06/069268
CTRI/2024/06/069268Not yet recruitingPhase 3

An Open Labelled Randomised Controlled Clinical Study to evaluate the efficacy of Ksheerbala Tail Nasya and Ashwagandha Tail Nasya in the management of cervical spondylosis - NI

Institute for Ayurved Studies & Research0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1 Patients willing to sign the consent form.
  • 2 Patients aged between 25 and 55 yrs of either sex.
  • 3 Patients having signs and symptoms of cervical spondylosis exceeding not more than 3 years with or without radiological changes.
  • 4 Patients fit for Nasya Karma.

Exclusion Criteria

  • 1 Patients having age below 25 and above 55 yrs of either sex.
  • 2 Patients with chronicity of more than 3 years.
  • 3 Patients unfit for Nasya karma.
  • 4 Patients not willing for the Nasya karma.
  • 5 Patients diagnosed with Myelopathy or stenosis of Spinal Canal, and other related conditions like Ankylosing spondylitis.
  • 6 Patient diagnosed with Tuberculosis of spine, spinal tumors, Vascular lesions, Neoplasms, history of trauma, fractures and surgical history.
  • 7 Patients having any other systemic disorders like cardiac disease, renal diseases and hypertension or endocrinal disorders.
  • 8 Pregnant or lactating mothers.

Investigators

Sponsor
Institute for Ayurved Studies & Research

Similar Trials